-
Are Some Drug Prices Too Low?
What is the relationship between lower drug prices and drug shortages. In a new JAMA viewpoint, CP3's Inma Hernandez, PharmD, PhD, Tina Batra Hershey, JD, MPH, and Julie M. Donohue, PhD untangle the connection.
Read the paper -
US Drug Prices Rose 3x Faster than Inflation
The latest paper from Drs. Hernandez, San-Juan-Rodriguez, Good, and Gellad examines the effect of manufacturer discounts on list prices of brand name drugs in the US. The authors found that, despite the discounts, prices still rose three times faster than inflation over the period of 2007-2018.
Read the paper here -
Challenges for Biosimilars
What are the challenges for biosimilars? What does the delay in Humira biosimilar entry mean for patients when new, better drugs are available? Thoughts from CP3's Dr. Walid Gellad and Dr. Bernie Good are in JAMA.
Read the paper here -
Dentists Prescribe Excessive Opioids
Dr. Katie Suda is lead author of a pivotal study examining patterns of excessive opioid prescribing among dentists.
Read more about the study
Improving the Quality, Safety and Efficiency of Medication Use
While prescription drugs are used by 80% of Americans, the improper, unsafe use of medications leads to billions of dollars of avoidable healthcare costs. The goal of the CP3 research program is to improve patient and prescriber decision-making, and inform the regulation and coverage of pharmaceuticals.
